Managed Access Programs for TQJ230, Pelacarsen

NCT07000695 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Atherosclerotic Cardiovascular Disease, ASCVD

Interventions

DRUG: Pelacarsen

Sponsor

Novartis Pharmaceuticals